APA (7th ed.) Citation

Viscusi, E., Minkowitz, H., Winkle, P., Ramamoorthy, S., Hu, J., & Singla, N. (2019). HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: Results from the phase 3 EPOCH 2 study. Hernia : the journal of hernias and abdominal wall surgery, 23(6), 1071-1080. https://doi.org/10.1007/s10029-019-02023-6

Chicago Style (17th ed.) Citation

Viscusi, E., H. Minkowitz, P. Winkle, S. Ramamoorthy, J. Hu, and N. Singla. "HTX-011 Reduced Pain Intensity and Opioid Consumption Versus Bupivacaine HCl in Herniorrhaphy: Results from the Phase 3 EPOCH 2 Study." Hernia : The Journal of Hernias and Abdominal Wall Surgery 23, no. 6 (2019): 1071-1080. https://doi.org/10.1007/s10029-019-02023-6.

MLA (9th ed.) Citation

Viscusi, E., et al. "HTX-011 Reduced Pain Intensity and Opioid Consumption Versus Bupivacaine HCl in Herniorrhaphy: Results from the Phase 3 EPOCH 2 Study." Hernia : The Journal of Hernias and Abdominal Wall Surgery, vol. 23, no. 6, 2019, pp. 1071-1080, https://doi.org/10.1007/s10029-019-02023-6.